P95 has appointed Henk Hoornaert as Chief Commercial Officer (CCO). After two years of accelerated growth, this appointment will strengthen P95’s structure and improve business development, marking a further step towards a more stable and mature organization.

Largest study to provide a more accurate assessment of the incidence of Lassa fever infections expands in West Africa

A new public-private partnership – COVIDRIVE – announced today that it will begin studies to assess the effectiveness...

P95, a service provider specialized in epidemiology, statistics and pharmacovigilance, is happy to announce that...